Revvity Nears 52-Week High, but This Analyst Thinks Stock Can Climb Another 20%
Revvity Inc. (NYSE: RVTY ) drew new bullish coverage Monday as William Blair initiated the stock with an Outperform rating, arguing that artificial intelligence could become a net tailwind for the company. Life Sciences Recovery Could Drive Estimates Higher Analyst Matt Larew said improving life sciences end markets may not be fully reflected in consensus estimates. The segment accounts for about 52% of Revvity's revenue. Pharma and biotech funding is also improving, which could support stronger demand across Revvity's portfolio. William Blair expects AI to provide an incremental boost to Revvity's preclinical business. However, the company's high-throughput screening, or HTS, business could face some pressure. The firm's checks also suggest Revvity's software business is more resilient than investors may believe. William Blair said Revvity's main competitive advantage comes from proprietary data and deeply embedded customer workflows rather than software code that competitors can easily replicate. See More: Top Value Stocks AI Narrative Could Become a Tailwind Revvity shares trade at 25.6 times William Blair's 2027 earnings-per-share estimate. That compares with the stock's 10-yea
Revvity Inc. (NYSE: RVTY ) drew new bullish coverage Monday as William Blair initiated the stock with an Outperform rating, arguing that artificial intelligence could become a net tailwind for the company. Life Sciences Recovery Could Drive Estimates Higher Analyst Matt Larew said improving life sciences end markets may not be fully reflected in consensus estimates. The segment accounts for about 52% of Revvity's revenue.
Pharma and biotech funding is also improving, which could support stronger demand across Revvity's portfolio. William Blair expects AI to provide an incremental boost to Revvity's preclinical business. However, the company's high-throughput screening, or HTS, business could face some pressure. The firm's checks also suggest Revvity's software business is more resilient than investors may believe.
William Blair said Revvity's main competitive advantage comes from proprietary data and deeply embedded customer workflows rather than software code that competitors can easily replicate. 6 times William Blair's 2027 earnings-per-share estimate. 2 times and represents a slight discount to its peer group. Larew said recent price action has started to reflect expectations for stronger revenue growth and margin expansion.
However, he sees additional upside as the AI narrative around Revvity's Signals software business shifts from a perceived competitive risk to a potential growth driver. The analyst sees more than 20% upside over the next year, supported by positive earnings estimate revisions. William Blair said Revvity appears to be entering a beat-and-raise cycle as its end markets recover. The firm initiated coverage with an Outperform rating.
22. 04 million estimate. "Revvity delivered a strong second quarter, with results above our expectations and encouraging signs of increased demand across our customer base," said Prahlad Singh, president and CEO of Revvity. 30.
27 per share. 84 billion. 858 billion. 15 at the time of publication on Tuesday.
28, according to Pro data. Photo via Shutterstock Read Also: Joe Rogan Says Money Is So Deeply Entangled In Politics That Removing It Entirely 'Seems Ridiculous To People'